The Mirex Network Roadmap Update went live on X on September 8, 2026. The post said MIREX (ticker: MRX) and LUMIRA development will follow a five-step order instead of fixed launch dates.
The project builds real-world asset, or RWA, tools that turn physical or business assets into blockchain tokens.
The network describes itself as a platform where token holders can take part in revenue-sharing models tied to real businesses. According to the Mirex Network Roadmap Update, KYC, short for Know Your Customer verification, sits at the top of the new priority list.
The Mirex Network Roadmap Update lists five milestones in the order the team plans to complete them, moving from technical setup toward ecosystem growth.
Step | Milestone | Detail |
1 | KYC Slots Integration | Current priority and first milestone in active development |
2 | Gamified RWA Funding | Games added to the app to support RWA funding |
3 | RWA Events and Partnerships | Events built into the app; partnership reveals expected here |
4 | RWA Marketing | Larger marketing push once infrastructure is ready |
5 | First LUMIRA Release | Rollout tied to completion of set milestones |
Strengthening MRX liquidity
CEX (Centralized Exchange) listing plans
Additional ecosystem development
The project said these are not separate major features. They stay part of the broader plan covered in this Mirex Network Roadmap Update.
Source: Official X Post, 08 September 2026
The project said development timelines often shift due to unexpected delays. Instead of committing to fixed dates, the team will share the exact build order it plans to follow.
This lets holders track progress by milestone rather than by calendar date. The post added that shifting plans are common in blockchain development, and a clear order can reduce confusion when timelines move.
Fixed dates can also create pressure to rush unfinished work. A milestone-based order gives the team room to complete each step properly before moving to the next one.
MRX traded at 1.29 dollars against USDT on PancakeSwap at the time of writing, September 9, 2026. The pair showed a market capitalization near 34.8 million dollars and a fully diluted valuation close to the same figure. Liquidity stood near 98,000 dollars, based on DexScreener data.
The token moved up about 1.49 percent over the past hour but slipped 1.35 percent over six hours, while the 24-hour change stayed flat near 0.07 percent.
Trading volume over 24 hours reached about 22,000 dollars, split evenly between buy and sell volume. The chart recorded 283 total transactions, with 148 buys against 135 sells.
Chart data shows price movement around the same period as the Mirex Network Roadmap Update, though the project has not confirmed a direct link between the two.
Note: Prices can change quickly, so figures may not reflect the latest value. Readers should check a live price tracker for current data.
Source: DexScreener Chart
Placing KYC integration first is common among early-stage RWA projects still finalizing compliance steps. It suggests the team is prioritizing regulatory groundwork before scaling marketing or exchange listings.
A staged sequence also gives outside observers a way to track progress milestone by milestone, rather than waiting on a single launch date that could slip.
The Mirex Network Roadmap Update does not name a confirmed CEX listing, which keeps the plan in an early execution phase. The five-step order reads as a development sequence rather than a guaranteed timeline, and readers should treat it that way.
The Mirex Network Roadmap Update sets a build-first order for MIREX and LUMIRA, starting with KYC integration. The project said the focus stays on utility first, followed by long-term growth.
The five-step order gives holders a clearer way to track progress than a fixed date ever did. Each milestone builds on the one before it, from compliance work to gamified funding to marketing and the first LUMIRA release.
Mirex Network said this is only the early stage of a larger plan. Further updates are expected as each milestone is completed.
YMYL Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not a price prediction or a guarantee of returns. Readers should do their own research before making any decisions related to MIREX, LUMIRA, or any other crypto asset.
